Home > Qtrly Results > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Quarterly Results Analysis [Dec2025]

SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Quarterly Results

Consolidated Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Revenues ₹115 Cr ₹122 Cr ₹117 Cr ₹149 Cr ₹128 Cr ₹102 Cr ₹87 Cr ₹75 Cr
Expenses ₹94 Cr ₹103 Cr ₹101 Cr ₹131 Cr ₹113 Cr ₹90 Cr ₹77 Cr ₹65 Cr
Operating Income ₹21 Cr ₹18 Cr ₹16 Cr ₹18 Cr ₹15 Cr ₹12 Cr ₹10 Cr ₹9 Cr
Other Income ₹6 Cr ₹5 Cr ₹6 Cr ₹7 Cr ₹4 Cr ₹4 Cr ₹1 Cr ₹3 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹25 Cr ₹22 Cr ₹20 Cr ₹23 Cr ₹17 Cr ₹15 Cr ₹10 Cr ₹10 Cr
Profit After Tax ₹19 Cr ₹17 Cr ₹16 Cr ₹18 Cr ₹13 Cr ₹11 Cr ₹8 Cr ₹7 Cr
EPS ₹0.20 ₹0.18 ₹0.17 ₹0.19 ₹0.14 ₹0.12 ₹0.08 ₹0.08
Industry Peers & Returns1W1M1Y
SYNCOM FORMULATIONS (INDIA) -4.1% -0.8% -24.5%
SUN PHARMACEUTICAL INDUSTRIES 0.3% 9% 8.6%
DIVIS LABORATORIES 1.9% 5.9% 12.6%
CIPLA 1.6% 1.8% -7.9%
TORRENT PHARMACEUTICALS 0.6% 9.5% 45%
DR REDDYS LABORATORIES -1.5% 5.7% 14.5%
MANKIND PHARMA 9.9% 5.8% -2%
ZYDUS LIFESCIENCES 1.6% 4.2% 6%
LUPIN 2.5% 7% 21.9%

SYNCOM FORMULATIONS (INDIA) Quarterly Revenues

Revenues
Q-o-Q

-5.40 %

Y-o-Y

-9.72 %

Quarters Revenues % Change
Dec2025 ₹115 Cr
-5.40
Sep2025 ₹122 Cr
4.12
Jun2025 ₹117 Cr
-21.48
Mar2025 ₹149 Cr
16.74
Dec2024 ₹128 Cr
24.65
Sep2024 ₹102 Cr
17.26
Jun2024 ₹87 Cr
17.01
Mar2024 ₹75 Cr -

SYNCOM FORMULATIONS (INDIA) Quarterly Operating Profit

Operating Profit
Q-o-Q

15.27 %

Y-o-Y

43.99 %

Quarters Operating Profit % Change
Dec2025 ₹21 Cr
15.27
Sep2025 ₹18 Cr
16.40
Jun2025 ₹16 Cr
-10.95
Mar2025 ₹18 Cr
20.52
Dec2024 ₹15 Cr
21.12
Sep2024 ₹12 Cr
16.33
Jun2024 ₹10 Cr
10.93
Mar2024 ₹9 Cr -
Operating Margins
Q-o-Q

21.83 %

Y-o-Y

59.48 %

Quarters Operating Margin% % Change
Dec2025 18.42%
21.83
Sep2025 15.12%
11.83
Jun2025 13.52%
13.42
Mar2025 11.92%
3.20
Dec2024 11.55%
-2.86
Sep2024 11.89%
-0.75
Jun2024 11.98%
-5.22
Mar2024 12.64% -

SYNCOM FORMULATIONS (INDIA) Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

13.89 %

Y-o-Y

45.43 %

Quarters Profit After Tax % Change
Dec2025 ₹19 Cr
13.89
Sep2025 ₹17 Cr
5.38
Jun2025 ₹16 Cr
-10.96
Mar2025 ₹18 Cr
36.10
Dec2024 ₹13 Cr
17.04
Sep2024 ₹11 Cr
45.53
Jun2024 ₹8 Cr
3.11
Mar2024 ₹7 Cr -
PAT Margins
Q-o-Q

20.38 %

Y-o-Y

61.14 %

Quarters PAT Margin(%) % Change
Dec2025 16.42 %
20.38
Sep2025 13.64 %
1.19
Jun2025 13.48 %
13.37
Mar2025 11.89 %
16.68
Dec2024 10.19 %
-6.17
Sep2024 10.86 %
24.11
Jun2024 8.75 %
-11.88
Mar2024 9.93 % -

SYNCOM FORMULATIONS (INDIA) Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

11.11 %

Y-o-Y

42.86 %

Quarters EPS % Change
Dec2025 ₹0.2
11.11
Sep2025 ₹0.18
5.88
Jun2025 ₹0.17
-10.53
Mar2025 ₹0.19
35.71
Dec2024 ₹0.14
16.67
Sep2024 ₹0.12
50.00
Jun2024 ₹0.08
0.00
Mar2024 ₹0.08 -

You may also like the below Video Courses